Issue Type: Abuses of Government Programs and Regulations

In challenge narrative 12/9/20

  • Solving Pharma’s Shkreli Problem

  • Rising Drug Costs Only Getting Worse

  • Express Scripts Turns to a Compounder to Avoid a Turing Drug

  • Remdesivir Less Expensive for “Government Programs”? Not So Fast.

    Remdesivir Less Expensive for “Government Programs”? Not So Fast.

  • Expansion of the Medicare 340B Payment Program

  • Impact of President Trump’s Proposed 340B Hospital Eligibility Threshold

    Impact of President Trump’s Proposed 340B Hospital Eligibility Threshold

  • Association of Rebates in Part D with Patient OOP and Federal Spending

    Association of Rebates in Part D with Patient OOP and Federal Spending

  • The 340B Program: Hospitals Profit by Reaching Affluent Communities

  • Cost Consequences of the 340B Drug Discount Program

  • Limits on Medicare’s Ability to Control Rising Spending on Cancer Drugs